Health TrialsbyHealthPanel

Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension

ConditionsHypertensionHypertension (HTN)Artery DiseaseTarget Organ Damage
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDejthidaNathaphong

About this trial

To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults ≥18 years with diagnosed hypertension by a clinician, both untreated and treated, including successfully treated participants.

Imaging evidence of at least 1 list of

Common carotid artery

Renal artery

Disqualifiers

Fatal pathology and imaging

Pediatric or pregnant participants

Small vessel angiogram

Intravascular endoscopy

Trial population

Hypertensive patient who underwent the radiographic measurement of structure and function of carotid artery, renal artery or femoral artery

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Diameter measurement

    Other intervention

    Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery

  • Velocity

    Other intervention

    Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)

Treatment groups

100 Participants
are divided into 3 treatment groups
Group A: Common Carotid Artery2 interventions
Group B: Renal Artery2 interventions
Group C: Femoral Artery2 interventions

Trial outcomes

Primary outcomes

1

Median of diameter of common carotid artery, renal artery and femoral artery in hypertension patients.

Radiographic measurement includes ultrasonography, CT/MR imaging, and intravascular contrast media imaging that measure the diameter in cm. unit of any side of common carotid artery and/or renal artery and/or femoral artery in hypertension patients.

Time frame
1 years

Secondary outcomes

1

Common Carotid Artery Function

Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Common Carotid Artery

Time frame
1 year
2

Renal Artery Function

Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Renal Artery

Time frame
1 year
3

Femoral Artery Function

Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Femoral Artery

Time frame
1 year

Other outcomes

1

All-cause mortality outcomes

Incidence of mortality rate (case per 1,000 person-year) of hypertensive participants were underwent measurement the diameter one side of one of common carotid artery and/or renal artery and/or femoral artery

Time frame
1 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

DejthidaNathaphong

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: